The substantial decrease in the phospho-p130Cas level with Crk/CrkL double knockdown in GBM cells is consistent with our previous studies with fibroblasts (51, 52) and colorectal and pancreatic cancer cell lines (42). This evidence concerns the gene CRK and pancreatic neoplasm.